Afghanistan vs Chad: HIV-positive TB patients on ART (antiretroviral therapy)
Afghanistan
100.0%
in 2024
Chad
100.0%
in 2024
Afghanistan rank
1st
Chad rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Afghanistan
- Chad
How they compare
Afghanistan currently reports 100.0% against 100.0% in Chad, a difference of 0.0%.
The two have swapped places 3 times across 12 shared years of data; in 2010 it was Afghanistan ahead.
Afghanistan ranks 1st and Chad ranks 1st of 144 countries.
Afghanistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 83.9% | 62.6% | 21.3% | Afghanistan |
| 2020s | 100.0% | 99.4% | 0.6% | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Afghanistan or Chad?
- Afghanistan, at 100.0% against 100.0% in Chad as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Afghanistan and Chad?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Chad?
- 12 years are reported by both, from 2010 to 2024.
- How do Afghanistan and Chad rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Afghanistan ranks 1st and Chad ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.